Moleculin Biotech (MBRX) Interest Expenses (2015 - 2026)

Moleculin Biotech's Interest Expenses history runs 11 years deep, the most recent figure standing at $41000.0 for Q4 2025.

• In Q4 2025, Interest Expenses rose 5.13% year-over-year to $41000.0; the TTM figure through Dec 2025 stood at $159000.0 (up 9.66% YoY), while the FY2025 annual figure was $43.7 million, up 13.21% from the prior year.
• Interest Expenses for Q4 2025 stood at $41000.0, up from $40000.0 in the prior quarter.
• The five-year high for Interest Expenses was $41000.0 in Q4 2025, with the low at $21000.0 in Q3 2022.
• The 5-year median for Interest Expenses is $36500.0 (2021), against an average of $35300.0.
• The sharpest annual moves came in 2021 and 2022: Interest Expenses surged 135.0% in 2021, then tumbled 40.0% in 2022.
• Moleculin Biotech's Interest Expenses stood at $35000.0 in 2021, then grew by 8.57% to $38000.0 in 2022, then slumped by 34.21% to $25000.0 in 2023, then jumped by 56.0% to $39000.0 in 2024, then climbed by 5.13% to $41000.0 in 2025.
• Business Quant data shows MBRX's Interest Expenses at $41000.0 in Q4 2025, $40000.0 in Q3 2025, and $39000.0 in Q2 2025.